Assembly Biosciences (ASMB) insider buying

Healthcare · Biotechnology · Market cap $327M

5 open-market purchases of ASMB by Assembly Biosciences's executives and directors since January 2024, worth $541,405 in total, from SEC Form 4 filings.

The most recent: Michael Houghton bought $49,983 on December 30, 2024.

The biggest buyer over the period is Alexander Schornstein: 4 purchases, $491,421.

By year

YearPurchasesValue
20245$541,405

Biggest buyers

InsiderBuysValue
Alexander Schornstein
4$491,421
Michael Houghton
1$49,983

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Dec 30, 2024 Michael Houghton
3,202$15.61$49,983 Form 4
Oct 8, 2024 Alexander Schornstein
10,000$14.58$145,800 Form 4
Jul 5, 2024 Alexander Schornstein
4,438$12.52$55,564 Form 4
Jul 3, 2024 Alexander Schornstein
4,562$12.29$56,067 Form 4
Jan 17, 2024 Alexander Schornstein
24,999$9.36$233,991 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ASMB.
Open ASMB in Investingly

Questions

Are Assembly Biosciences insiders buying the stock?

5 open-market purchases of ASMB by Assembly Biosciences's executives and directors since January 2024, worth $541,405 in total, from SEC Form 4 filings. The most recent: Michael Houghton bought $49,983 on December 30, 2024.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Assembly Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.